Live Breaking News & Updates on Psych Congress

Stay updated with breaking news from Psych congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Clears Cingulate to File for Marketing Approval of

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application
Advancing Discussions with Commercialization Partners. ....

United States , Kansas City , Shanej Schaffer , Matt Kreps , Thomas Dalton , Ann Childress , Darrow Associates , Exchange Commission , Psych Congress First Annual Poster , Drug Administration , American Professional Society , Behavior Medicine Inc , Securities Exchange , Psych Congress , Platform Technology , Cingulate Inc , Date Sufficient , New Drug Application , Currently Using Immediate Release Booster , Precision Timed Release , Attention Deficit Hyperactivity Disorder , Cingulate Chairman , Behavior Medicine , Professional Society , Related Disorders , First Annual Poster ,

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently . ....

United States , Kansas City , Shanej Schaffer , Matt Kreps , Thomas Dalton , Ann Childress , Drug Administration , Behavior Medicine Inc , Platform Technology , Securities Exchange , Darrow Associates , Psych Congress First Annual Poster , Exchange Commission , Psych Congress , Cingulate Inc , American Professional Society , Date Sufficient , New Drug Application , Currently Using Immediate Release Booster , Precision Timed Release , Attention Deficit Hyperactivity Disorder , Cingulate Chairman , Behavior Medicine , Professional Society , Related Disorders , First Annual Poster ,

Castle Biosciences' IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"

Castle Biosciences' IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Derek Maetzold , Steve Johansson , Castle Bioscience , Castle Biosciences , Overall Mental Health Solution , Technology Solution , Mental Health America , Castle Biosciences Inc , Mental Health Week , Health Fitness , Mental Health In America , Psych Congress , Clinical Administration , Mental Health Month , Overall Mental Health , Medtech Breakthrough Awards , Medtech Breakthrough Award , Mental Health , Artificial Intelligence , New Technology Solution , Tech Breakthrough , Patient Experience , Medical Devices , Connected Healthcare , Medical Data ,

Late Breaking News From APSARD 2024 Conference

Check out these APSARD 2024 updates from Greg Mattingly, MD, president of the American Professional Society for ADHD and Related Disorders. ....

United States , Jeff Newcorn , Ann Childress , Joseph Biederman , David Goodman , Greg Mattingly , Margaret Sibley , World Federation , International Association For Child , J Adolesc Health , Washington University , Psych Congress , Drug Administration , American Professional Society , Centers For Disease , Midwest Research Group , Related Disorder , Disease Control , International Association , Adolescent Psychiatry , Grim Age , Integrated Data Exploratory Analysis ,

Medication Pipeline: Schizophrenia and PTSD

Here's an update on which medications are on the horizon for the treatment of schizophrenia and PTSD. ....

Exeter Hospital , New Hampshire , United States , Emil Kraepelin , Clin Neurosci , Karuna Therapeutics Inc , Minerva Neurosciences Inc , Wunderlichg Development , Public Benefit Corp , Psych Congress , Insight Meditation Society , Us Food Drug Administration , Brain Health , Seacoast Mental Health Center , Drug Administration , Karuna Therapeutics , Present Resulting From Too Much Dopamine , Nucleus Accumbens , Muscarinic Cholinergic , Receptors Decreasing , Negative Syndrome Scale , Cerevel Therapeutics , Cognitive Symptoms , Physiological Process , Cognitive Battery , Negative Symptoms ,